ATE150463T1 - Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen - Google Patents

Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen

Info

Publication number
ATE150463T1
ATE150463T1 AT92920743T AT92920743T ATE150463T1 AT E150463 T1 ATE150463 T1 AT E150463T1 AT 92920743 T AT92920743 T AT 92920743T AT 92920743 T AT92920743 T AT 92920743T AT E150463 T1 ATE150463 T1 AT E150463T1
Authority
AT
Austria
Prior art keywords
quinolone
compound
lactam
moiety
steps
Prior art date
Application number
AT92920743T
Other languages
English (en)
Inventor
Ronald Eugene White
Thomas Prosser Demuth Jr
Original Assignee
Procter & Gamble Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma
Application granted granted Critical
Publication of ATE150463T1 publication Critical patent/ATE150463T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92920743T 1991-10-01 1992-09-28 Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen ATE150463T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76961591A 1991-10-01 1991-10-01

Publications (1)

Publication Number Publication Date
ATE150463T1 true ATE150463T1 (de) 1997-04-15

Family

ID=25085987

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92920743T ATE150463T1 (de) 1991-10-01 1992-09-28 Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen

Country Status (22)

Country Link
US (1) US5281703A (de)
EP (1) EP0606336B1 (de)
KR (1) KR100253825B1 (de)
CN (1) CN1046523C (de)
AT (1) ATE150463T1 (de)
AU (1) AU667837B2 (de)
BR (1) BR9206590A (de)
CA (1) CA2120493A1 (de)
CZ (1) CZ73194A3 (de)
DE (1) DE69218445T2 (de)
DK (1) DK0606336T3 (de)
ES (1) ES2101119T3 (de)
FI (1) FI941490L (de)
GR (1) GR3023227T3 (de)
HU (1) HUT67423A (de)
MX (1) MX9205620A (de)
NO (1) NO304599B1 (de)
NZ (1) NZ244557A (de)
PT (1) PT100920B (de)
RU (1) RU2130938C1 (de)
SK (1) SK37594A3 (de)
WO (1) WO1993007154A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
DE69431684T2 (de) * 1993-12-28 2003-03-20 Kao Corp., Tokio/Tokyo Vernetzte Zellulosefasern, absorbierende Papiere und absorbierende Elemente, Deckschicht und absorbierende Gegenstände, wobei diese Fasern Verwendung finden
EP0775114B1 (de) * 1994-08-02 2000-03-22 The Procter & Gamble Company Verfahren zur herstellung von antimikrobiellen verbindungen
EP0775145A1 (de) * 1994-08-02 1997-05-28 The Procter & Gamble Company Verfahren zur herstellung von quinolonyl laktam antimikorbielle verbindungen und zwischenprodukte
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0695753A1 (de) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem-Derivate mit einem bicyclischen Substituenten, Verfahren zu ihrer Herstellung und ihre Verwendung
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
WO1999028308A1 (en) * 1997-11-29 1999-06-10 Truett William L Antibiotics and process for preparation
US6437119B1 (en) 1998-05-07 2002-08-20 William Lawrence Truett Compounds formed from two or three antibiotics and their processes of preparation
US6947844B2 (en) * 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) * 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
IN191798B (de) 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
DE60101724T2 (de) * 2001-03-30 2004-12-02 Dar Al Dawa Development, And Investment Co. Chinolin-4-on Derivate und deren Verwendung als Antibiotika
IL151012A0 (en) * 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
CN1780846A (zh) * 2003-03-05 2006-05-31 Rib－X医药品有限公司 双官能杂环化合物及其制备和使用方法
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US20070270357A1 (en) * 2003-11-18 2007-11-22 Farmer Jay J Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU63689A (en) * 1988-03-31 1991-06-30 Hoffmann La Roche Acyl derivatives
EP0997466A1 (de) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Antimikrobielle Laktamchinolone
EP0366193A3 (de) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Antimikrobielle Quinolonyllactame
ATE194353T1 (de) * 1988-10-24 2000-07-15 Norwich Eaton Pharma Antimikrobielle quinolonyllactamester
ATE176473T1 (de) * 1988-10-24 1999-02-15 Procter & Gamble Pharma Antimikrobielle fluorochinolonylcephemderivate
ZA912279B (en) * 1990-04-09 1992-02-26 Hoffmann La Roche Carbapenem compounds
DK0525057T3 (da) * 1990-04-18 2000-07-31 Procter & Gamble Pharma Antimikrobielle quinolonyllactamer

Also Published As

Publication number Publication date
RU2130938C1 (ru) 1999-05-27
BR9206590A (pt) 1995-04-25
AU2693892A (en) 1993-05-03
CN1075146A (zh) 1993-08-11
FI941490A7 (fi) 1994-05-02
DK0606336T3 (da) 1997-04-14
CA2120493A1 (en) 1993-04-15
PT100920A (pt) 1993-10-29
MX9205620A (es) 1993-12-01
NO941108D0 (no) 1994-03-25
DE69218445T2 (de) 1997-08-07
SK37594A3 (en) 1995-02-08
WO1993007154A1 (en) 1993-04-15
NZ244557A (en) 1996-02-27
GR3023227T3 (en) 1997-07-30
EP0606336B1 (de) 1997-03-19
FI941490L (fi) 1994-05-02
ES2101119T3 (es) 1997-07-01
CN1046523C (zh) 1999-11-17
DE69218445D1 (de) 1997-04-24
HUT67423A (en) 1995-04-28
AU667837B2 (en) 1996-04-18
HU9400940D0 (en) 1994-06-28
NO304599B1 (no) 1999-01-18
PT100920B (pt) 1999-07-30
CZ73194A3 (en) 1994-11-16
KR100253825B1 (ko) 2000-05-01
EP0606336A1 (de) 1994-07-20
FI941490A0 (fi) 1994-03-30
NO941108L (no) 1994-05-31
US5281703A (en) 1994-01-25

Similar Documents

Publication Publication Date Title
ATE150463T1 (de) Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen
RU94018240A (ru) Способ получения антимикробных хинолониллактамов
DE3587546D1 (de) Verfahren zur Herstellung von optisch aktiven Acyloxyazetidinonen.
CA2238864A1 (en) Method for the synthesis of a benzimidazole compound
DE69231874D1 (de) Verfahren zur herstellung von 4-substituierten azetidinon-derivaten
DE69515882D1 (de) Verfahren zur herstellung von antimikrobiellen verbindungen
ATE168693T1 (de) Verfahren zur herstellung von beta- lactamderivaten und zwischenprodukt für ihre synthese
ATE127809T1 (de) Verfahren zur herstellung von verbindungen zur behandlung der gutartigen prostatahypertrophie.
DE3382761D1 (de) Verfahren zur Herstellung von Penem-Verbindungen.
ATE221876T1 (de) Verfahren zur herstellung von zyklischen verbindungen
NO992058L (no) FremgangsmÕte for fremstilling av fysostigminkarbamatderivater fra eseretoler
CA2196539A1 (en) Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
DE69714749D1 (de) Verfahren zur herstellung von 3-amino-2-hydroxy-1-propylethern
NO931105L (no) Fremgangsmaate for fremstilling av et 4-substituert azetidinonderivat
DE69706632D1 (de) Verfahren zur herstellung von 3-norcephem-verbindungen
DE3864163D1 (de) Beta-lactam-verbindungen und verfahren zu deren herstellung.
ATE210115T1 (de) Verfahren zur herstellung von (1'r,3s,4r)4- acylthioazetidinonen
ATE116288T1 (de) Verfahren zur herstellung von sulfonylisocyanaten.
EP0837066A4 (de) Verbessertes verfahren zur herstellung von penicillin g phenyl-ester
MY105332A (en) Process for preparing penem esters
ATE226207T1 (de) Verfahren zur herstellung von beta-lactam verbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee